Citation 129597

BADRIA,FA: MC CHESNEY,JD: HALIM,AF: ZAGHLOUL,AM: EL SAYED,KA:. (1995). TIME COURSE AND INHIBITION OF STAVAROSIDE K, VERATRAMIN AND CERVINE-INDUCED HEMOLYSIS BY OTHER PREGNANE GLYCOSIDES AND VERATRUM ALKALOIDS.. 50(6)

Citation Details

Title	TIME COURSE AND INHIBITION OF STAVAROSIDE K, VERATRAMIN AND CERVINE-INDUCED HEMOLYSIS BY OTHER PREGNANE GLYCOSIDES AND VERATRUM ALKALOIDS.
Authors	BADRIA,FA: MC CHESNEY,JD: HALIM,AF: ZAGHLOUL,AM: EL SAYED,KA:
Year	1995
Volume	50
Issue	6

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE J	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE K	ACTIVE
2	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE C	WEAK ACTIVITY
3	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE D	WEAK ACTIVITY
4	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE D	WEAK ACTIVITY
5	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE D	WEAK ACTIVITY
6	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE E	WEAK ACTIVITY
7	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE E	WEAK ACTIVITY
8	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STAVAROSIDE E	WEAK ACTIVITY
9	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMINESTAVAROSIDE F	WEAK ACTIVITY
10	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMINESTAVAROSIDE F	WEAK ACTIVITY
11	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMINESTAVAROSIDE F	WEAK ACTIVITY
12	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CEVINE	ACTIVE
13	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZYGADENINE,ANGELOYL-OXY:	ACTIVE
14	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZYGADENINE,ANGELOYL-OXY:	ACTIVE
15	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZYGADENINE,ANGELOYL-OXY:	ACTIVE
16	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZYGADENINE	ACTIVE
17	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZYGADENINE	ACTIVE
18	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZYGADENINE	WEAK ACTIVITY
19	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VERATRIDINE	ACTIVE
20	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VERATRIDINE	ACTIVE
21	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VERATRIDINE	ACTIVE
22	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JERVINE-3-O-BETA-D-GLUCOSIDEJERVINE	ACTIVE
23	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JERVINE-3-O-BETA-D-GLUCOSIDEJERVINE	ACTIVE
24	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JERVINE-3-O-BETA-D-GLUCOSIDEJERVINE	ACTIVE
25	HEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VERATRAMINE	ACTIVE
26	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBIJERVINEVERATRAMINE	WEAK ACTIVITY
27	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBIJERVINEVERATRAMINE	WEAK ACTIVITY
28	ANTIHEMOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUBIJERVINEVERATRAMINE	ACTIVE

Citation 129597

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1